Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans
Josephine Jüttner, Arnold Szabó, Brigitte Gross Scherf, Rei Morikawa, Santiago B. Rompani, Miguel Teixeira, Péter Hantz, Tamás Szikra, Federico Esposti, Cameron S. Cowan, Arjun Bharioke, Claudia P. Patino-Alvarez, Özkan Keles, Chiara N. Roth, Ákos Kusnyerik, Nadine Gerber-Hollbach, Thierry Azoulay, Dominik Hartl, Arnaud Regis Krebs, Dirk Schübeler, Rozina Hajdu, Ákos Lukáts, János Németh, Zoltan Z. Nagy, Kun-Chao Wu, and 9 more
Abstract
Summary Targeting genes to specific neuronal or glial cell types is valuable both for understanding and for repairing brain circuits. Adeno-associated viral vectors (AAVs) are frequently used for gene delivery, but targeting expression to specific cell types is a challenge. We created a library of 230 AAVs, each with a different synthetic promoter designed using four independent strategies. We show that ~11% of these AAVs specifically target expression to neuronal and glial cell types in the mouse retina, mouse brain, non-human primate retina in vivo , and in the human retina in vitro . We demonstrate applications for recording, stimulation, and molecular characterization, as well as the intersectional and combinatorial labeling of cell types. These resources and approaches allow economic, fast, and efficient cell-type targeting in a variety of species, both for fundamental science and for gene therapy.
Abstract of "Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans" by Josephine Jüttner, Arnold Szabó, Brigitte Gross Scherf et al., https://doi.org/10.1038/s41593-019-0431-2, used under its Creative Commons Attribution license (CC-BY); markup removed, otherwise unmodified.
Record
- Archive ID
- doi:10.1038/s41593-019-0431-2
- Published
- Jul 8, 2019
- Venue
- Nature Neuroscience
- DOI
- 10.1038/s41593-019-0431-2
- PubMed
- 31285614
- Categories
- Virus-based gene therapy research
- License
- cc-by
- Provenance
- openalex